Characterization of Human Cardiac Mesenchymal Stromal Cells and Their Extracellular Vesicles Comparing With Human Bone Marrow Derived Mesenchymal Stem Cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Cardiac regeneration with adult stem-cell (ASC) therapy is a promising field to address advanced cardiovascular diseases. In addition, extracellular vesicles (EVs) from ASCs have been implicated in acting as paracrine factors to improve cardiac functions in ASC therapy. In our work, we isolated human cardiac mesenchymal stromal cells (h-CMSCs) by means of three-dimensional organ culture (3D culture) during ex vivo expansion of cardiac tissue, to compare the functional efficacy with human bone-marrow derived mesenchymal stem cells (h-BM-MSCs), one of the actively studied ASCs. We characterized the h-CMSCs as CD90low, c-kitnegative, CD105positive phenotype and these cells express NANOG, SOX2, and GATA4. To identify the more effective type of EVs for angiogenesis among the different sources of ASCs, we isolated EVs which were derived from CMSCs with either normoxic or hypoxic condition and BM-MSCs. Our in vitro tube-formation results demonstrated that the angiogenic effects of EVs from hypoxia-treated CMSCs (CMSC-Hpx EVs) were greater than the well-known effects of EVs from BM-MSCs (BM-MSC EVs), and these were even comparable to human vascular endothelial growth factor (hVEGF), a potent angiogenic factor. Therefore, we present here that CD90lowc-kitnegativeCD105positive CMSCs under hypoxic conditions secrete functionally superior EVs for in vitro angiogenesis. Our findings will allow more insights on understanding myocardial repair.
Abstract
Cardiac regeneration with adult stem-cell (ASC) therapy is a promising field to address advanced cardiovascular diseases. In addition, extracellular vesicles (EVs) from ASCs have been implicated in acting as paracrine factors to improve cardiac functions in ASC therapy. In our work, we isolated human cardiac mesenchymal stromal cells (h-CMSCs) by means of three-dimensional organ culture (3D culture) during ex vivo expansion of cardiac tissue, to compare the functional efficacy with human bone-marrow derived mesenchymal stem cells (h-BM-MSCs), one of the actively studied ASCs. We characterized the h-CMSCs as CD90low, c-kitnegative, CD105positive phenotype and these cells express NANOG, SOX2, and GATA4. To identify the more effective type of EVs for angiogenesis among the different sources of ASCs, we isolated EVs which were derived from CMSCs with either normoxic or hypoxic condition and BM-MSCs. Our in vitro tube-formation results demonstrated that the angiogenic effects of EVs from hypoxia-treated CMSCs (CMSC-Hpx EVs) were greater than the well-known effects of EVs from BM-MSCs (BM-MSC EVs), and these were even comparable to human vascular endothelial growth factor (hVEGF), a potent angiogenic factor. Therefore, we present here that CD90lowc-kitnegativeCD105positive CMSCs under hypoxic conditions secrete functionally superior EVs for in vitro angiogenesis. Our findings will allow more insights on understanding myocardial repair.
참고문헌 (39)
- Benjamin EJ, "Heart Disease and Stroke Statistics-2019 Update : A Report From the American Heart Association", Circulation, 139, pp.e56~e528 (2019)
- Cambria E, "Translational cardiac stem cell therapy : advancing from first-generation to next-generation cell types", NPJ Regen Med, 2, pp.17~ (2017)
- Makkar RR, "Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction(CADUCEUS) : a prospective, randomised phase 1 trial", Lancet, 379, pp.895~904 (2012)
- Parizadeh SM, "Stem cell therapy : A novel approach for myocardial infarction", J Cell Physiol, 234, pp.16904~16912 (2019)
- Yun CW, "Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease", Int J Mol Sci, 20, pp.982~ (2019)
- Barile L, "Endogenous cardiac stem cells", Prog Cardiovasc Dis, 50, pp.31~48 (2007)
- Smith RR, "Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens", Circulation, 115, pp.896~908 (2007)
- Beltrami AP, "Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration", Cell, 114, pp.763~776 (2003)
- Cheng K, "Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction", J Am Heart Assoc, 3, pp.e001260~ (2014)
- Gude NA, "Chasing c-Kit through the heart : Taking a broader view", Pharmacol Res, 127, pp.110~115 (2018)
- Gago-Lopez N, "THY-1receptor expression differentiates cardiosphere-derived cells with divergent cardiogenic differentiation potential", Stem Cell Reports, 2, pp.576~591 (2014)
- Shen D, "Therapeutic benefits of CD90-negative cardiac stromal cells in rats with a 30-day chronic infarct", J Cell Mol Med, 22, pp.1984~1991 (2018)
- Eschenhagen T, "Cardiomyocyte Regeneration", Circulation, 136, pp.680~686 (2017)
- Agarwal U, "Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients", Circ Res, 120, pp.701~712 (2017)
- Bei Y, "Extracellular Vesicles in Cardiovascular Theranostics", Theranostics, 7, pp.4168~4182 (2017)
- Ibrahim A, "Exosomes : Fundamental Biology and Roles in Cardiovascular Physiology", Annu Rev Physiol, 78, pp.67~83 (2016)
- Zamani P, "The therapeutic and diagnostic role of exosomes in cardiovascular diseases", Trends Cardiovasc Med, 29, pp.313~323 (2018)
- Ibrahim Ahmed GE, "Exosomes as Critical Agents of Cardiac Regeneration Triggered by Cell Therapy", Stem Cell Reports, 2, pp.606~619 (2014)
- Sahoo S, "Exosomes and cardiac repair after myocardial infarction", Circ Res, 114, pp.333~344 (2014)
- Xue C, "Exosomes Derived from Hypoxia-Treated Human Adipose Mesenchymal Stem Cells Enhance Angiogenesis Through the PKA Signaling Pathway", Stem Cells Dev, 27, pp.456~465 (2018)
- Namazi H, "Exosomes secreted by hypoxic cardiosphere-derived cells enhance tube formation and increase pro-angiogenic miRNA", J Cell Biochem, 119, pp.4150~4160 (2018)
- Li TS, "Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells", J Am Coll Cardiol, 59, pp.942~953 (2012)
- Maleki M, "Comparison of mesenchymal stem cell markers in multiple human adult stem cells", Int J Stem Cells, 7, pp.118~126 (2014)
- Durocher D, "The cardiac transcription factors Nkx2-5and GATA-4 are mutual cofactors", EMBO J, 16, pp.5687~5696 (1997)
- Kim JT, "A fibrin-supported myocardial organ culture for isolation of cardiac stem cells via the recapitulation of cardiac homeostasis", Biomaterials, 48, pp.66~83 (2015)
- van Berlo JH, "c-kit+cells minimally contribute cardiomyocytes to the heart", Nature, 509, pp.337~341 (2014)
- "G K Harvard calls for retraction of dozens of studies by noted cardiac researcher" (2018)[URL]
- Kaiser J, "Suspect science leads to pause in stem cell trial", Science, 362, pp.513~ (2018)
- Epstein JA, "A Time to Press Reset and Regenerate Cardiac Stem Cell Biology", JAMA Cardiol, 4, pp.95~96 (2019)
- Sultana N, "Resident c-kit(+)cells in the heart are not cardiac stem cells", Nat Commun, 6, pp.8701~ (2015)
- Rege TA, "Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine", growth factor responses, 2006, pp.1763, 991~999
- Forte E, "TGFbeta-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies", Stem Cells Dev, 21, pp.3081~3090 (2012)
- Heikinheimo M, "Localization of transcription factor GATA-4 to regions of the mouse embryo involved in cardiac development", Dev Biol, 164, pp.361~373 (1994)
- Yilbas AE, "Activation of GATA4 gene expression at the early stage of cardiac specification", Front Chem, 2, pp.12~ (2014)
- Akazawa H, "Cardiac transcription factor Csx", Nkx2-5 : Its role in cardiac development and diseases, 2005, pp.107, 252~268
- Oldershaw R, "Human Cardiac-Mesenchymal Stem Cell-Like Cells, a Novel Cell Population with Therapeutic Potential", Stem Cells Dev, 28, pp.593~607 (2019)
- Lo Sicco C, "Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects : endorsement of macrophage polarization", Stem Cells Transl Med, 6, pp.1018~1028 (2017)
- Hernán GK, "Hypoxia inducible factor-1apotentiates jagged1-mediated angiogenesis by mesenchymal stemcell-derived exosome", Stem Cells, 35, pp.1747~1759 (2017)
- Gray WD, "Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology", Circ Res, 116, pp.255~263 (2015)
